
News|Articles|November 29, 2007
FDA's comment period for proposed sunscreen rule extended
FDA extends comment period for proposed sunscreen rule
Advertisement
The FDA announced it will be extending the comment period on the agency's proposed sunscreen regulation to Dec. 26. The comment period was set to expire on Nov. 26. Typically, comment periods for federal rules is 90 days. The sunscreen rule, when finalized, will amend the 1999 FDA final rule on sunscreen products that protect against ultraviolet B (UVB) rays and incorporates new testing and labeling requirements for products that protect against ultraviolet A (UVA) rays. Comments must be identified with Docket No. 1978N-0038 and can be submitted to
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Accepts Sandoz Applications for Generic Tirzepatide
2
Making Medication Management Services Measurable and Visible
3
New ACIP Charter May Potentially Delay Vaccine Recommendations
4
Amazon, Fleming Initiative Partner to Combat Antimicrobial Resistance
5































